{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=24600&ordering=-accession","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=24560&ordering=-accession","results":[{"accession":"CLO:0018428","name":"GM16754 cell","definition":"[' FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC']","term_type":"cell line"},{"accession":"CLO:0018427","name":"GM16753 cell","definition":"[' CYSTINURIA; CSNU SOLUTE CARRIER FAMILY 7, MEMBER 9; SLC7A9']","term_type":"cell line"},{"accession":"CLO:0018426","name":"GM16756 cell","definition":"[' FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2']","term_type":"cell line"},{"accession":"CLO:0018425","name":"GM16755 cell","definition":"[' FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC']","term_type":"cell line"},{"accession":"CLO:0018424","name":"GM16718 cell","definition":"[' DELETED IN AZOOSPERMIA; DAZ CHROMOSOME DELETION']","term_type":"cell line"},{"accession":"CLO:0018423","name":"GM16726 cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0018422","name":"GM16727 cell","definition":"[]","term_type":"cell line"},{"accession":"CLO:0018421","name":"GM16728 cell","definition":"[' RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2']","term_type":"cell line"},{"accession":"CLO:0018420","name":"GM16824 cell","definition":"[' GLIAL FIBRILLARY ACIDIC PROTEIN; GFAP ALEXANDER DISEASE']","term_type":"cell line"},{"accession":"CLO:0018419","name":"GM16807 cell","definition":"[' XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD']","term_type":"cell line"},{"accession":"CLO:0018418","name":"GM16859 cell","definition":"[' BLOOM SYNDROME; BLM RECQ PROTEIN-LIKE 3; RECQL3']","term_type":"cell line"},{"accession":"CLO:0018417","name":"GM16854 cell","definition":"[' COLLAGEN, TYPE I, ALPHA-2; COL1A2 OSTEOGENESIS IMPERFECTA, TYPE IV; OI4']","term_type":"cell line"},{"accession":"CLO:0018416","name":"GM16853 cell","definition":"[' COLLAGEN, TYPE I, ALPHA-2; COL1A2 OSTEOGENESIS IMPERFECTA, TYPE IV; OI4']","term_type":"cell line"},{"accession":"CLO:0018415","name":"GM16852 cell","definition":"[' OSTEOGENESIS IMPERFECTA, TYPE IV; OI4 COLLAGEN, TYPE I, ALPHA-2; COL1A2']","term_type":"cell line"},{"accession":"CLO:0018414","name":"GM16851 cell","definition":"[' OSTEOGENESIS IMPERFECTA, TYPE IV; OI4 COLLAGEN, TYPE I, ALPHA-2; COL1A2']","term_type":"cell line"},{"accession":"CLO:0018413","name":"GM16835 cell","definition":"[' COLLAGEN, TYPE I, ALPHA-2; COL1A2 OSTEOGENESIS IMPERFECTA, TYPE IV; OI4']","term_type":"cell line"},{"accession":"CLO:0018412","name":"GM16826 cell","definition":"[' ALEXANDER DISEASE GLIAL FIBRILLARY ACIDIC PROTEIN; GFAP']","term_type":"cell line"},{"accession":"CLO:0018411","name":"GM16825 cell","definition":"[' ALEXANDER DISEASE GLIAL FIBRILLARY ACIDIC PROTEIN; GFAP']","term_type":"cell line"},{"accession":"CLO:0018410","name":"ND06791 cell","definition":"[' ISCHEMIC STROKE']","term_type":"cell line"},{"accession":"CLO:0018409","name":"ND06792 cell","definition":"[' POPULATION/CONVENIENCE CONTROL']","term_type":"cell line"}]}